Cure8 news brief
Cure8 news brief
A high-profile IBD specialist joining a large GI group could expand access to expert IBD care, boost local research activity, and help train new gastroenterologists—changes that may affect patients in South Florida and beyond.
IBD patients and caregivers in South Florida, clinicians and gastroenterology practices, researchers interested in IBD clinical research and fellowship training programs.
Gastro Health named Dr. Maria Abreu SVP of inflammatory bowel disease clinical care and innovation and announced she will begin seeing patients in Miami in January 2027.
Her responsibilities will include leading regional and national IBD care initiatives, overseeing clinical research efforts, assisting with physician recruitment, and helping develop Gastro Health’s proposed GI fellowship program with Florida International University’s Herbert Wertheim College of Medicine. Dr.
Abreu previously served as executive director of the F. Widjaja IBD Institute at Cedars-Sinai and directed the Crohn’s & Colitis Center at the University of Miami for more than a decade.
She is a past president of the American Gastroenterological Association, a former chair of the International Organization for the Study of Inflammatory Bowel Disease, and a recipient of the 2019 Sherman Prize for IBD research and treatment. The Crohn’s & Colitis Foundation will give her a 2027 Women of Distinction in Medicine award.
This is a personnel announcement from Becker's ASC; it reports on Dr. Abreu’s appointment and planned roles but does not present clinical trial data or new treatment guidance.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.